Paxillin anticorps (AA 305-559)
Aperçu rapide pour Paxillin anticorps (AA 305-559) (ABIN2331031)
Antigène
Voir toutes Paxillin (PXN) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Épitope
- AA 305-559
-
Réactivité croisée
- Poulet, Humain, Souris, Rat (Rattus)
-
Réactivité croisée (Details)
- Calculated cross reactivity: Ch Hu Mo Rt
-
Attributs du produit
- Paxillin (PXN)
-
Purification
- Purified by immunoaffinity chromatography.
-
Immunogène
- C-terminal part of recombinant chicken paxillin (aa305-559).
-
Isotype
- IgG1
-
-
-
-
Indications d'application
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Reconstitute with 1.2 % sodium acetate, PBS.
-
Buffer
- Supplied as a lyophilized powder from 1.2 % sodium acetate, 2 mg BSA, 0.01 mg sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- -20°C
-
-
- Paxillin (PXN)
-
Autre désignation
- Paxillin
-
UniProt
- P49024
-
Pathways
- Signalisation MAPK, EGFR Signaling Pathway, Response to Growth Hormone Stimulus, Cell-Cell Junction Organization, Maintenance of Protein Location, CXCR4-mediated Signaling Events, Signaling Events mediated by VEGFR1 and VEGFR2, Signaling of Hepatocyte Growth Factor Receptor, VEGF Signaling
Antigène
-